Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Neurogastroenterology and Motility
|
July 12, 2017
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT)
M Bashashati, J Fichna, F Piscitelli, et al.
Endoscopy
|
December 12, 2001
Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up
H D Allescher, M Storr, M Seige, et al.
Clinical and Experimental Immunology
|
October 1, 1995
The acute phase protein response in patients receiving subcutaneous IL-6
R E Banks, M A Forbes, M Storr, et al.
The International Journal of Artificial Organs
|
October 1, 2008
The effect of three different miniaturized blood purification devices on plasma cytokine concentration in an ex vivo model of endotoxinemia
M Haase, R Bellomo, I Baldwin, et al.
Cytokine
|
September 1, 1996
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood
D Clarke, P W Johnson, R E Banks, et al.
Neurogastroenterology and Motility
|
July 22, 2014
Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS
J Fichna, M Sobczak, A Mokrowiecka, et al.
Neurogastroenterology and Motility
|
December 22, 2017
FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS
P Mosińska, D Jacenik, M Sałaga, et al.
Journal of Crohn'S & Colitis
|
February 18, 2014
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
M Sałaga, A Mokrowiecka, P K Zakrzewski, et al.
Cytokine
|
May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects
R E Banks, M A Forbes, P M Patel, et al.
Zeitschrift Fur Gastroenterologie
|
December 11, 2012
[Diagnosis of oesophageal reflux by PH, impedance, and bilirubin measurement: recommendations of the German Society of Neurogastroenterology and of the working group for neurogastroenterology of the German Society for Digestive and Metabolic Diseases]
C Pehl, J Keller, H-D Allescher, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Neurogastroenterology and Motility
|
July 12, 2017
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT)
M Bashashati, J Fichna, F Piscitelli, et al.
Endoscopy
|
December 12, 2001
Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up
H D Allescher, M Storr, M Seige, et al.
Clinical and Experimental Immunology
|
October 1, 1995
The acute phase protein response in patients receiving subcutaneous IL-6
R E Banks, M A Forbes, M Storr, et al.
The International Journal of Artificial Organs
|
October 1, 2008
The effect of three different miniaturized blood purification devices on plasma cytokine concentration in an ex vivo model of endotoxinemia
M Haase, R Bellomo, I Baldwin, et al.
Cytokine
|
September 1, 1996
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood
D Clarke, P W Johnson, R E Banks, et al.
Neurogastroenterology and Motility
|
July 22, 2014
Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS
J Fichna, M Sobczak, A Mokrowiecka, et al.
Neurogastroenterology and Motility
|
December 22, 2017
FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS
P Mosińska, D Jacenik, M Sałaga, et al.
Journal of Crohn'S & Colitis
|
February 18, 2014
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
M Sałaga, A Mokrowiecka, P K Zakrzewski, et al.
Cytokine
|
May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects
R E Banks, M A Forbes, P M Patel, et al.
Zeitschrift Fur Gastroenterologie
|
December 11, 2012
[Diagnosis of oesophageal reflux by PH, impedance, and bilirubin measurement: recommendations of the German Society of Neurogastroenterology and of the working group for neurogastroenterology of the German Society for Digestive and Metabolic Diseases]
C Pehl, J Keller, H-D Allescher, et al.
Page
of 12